Eric Caumes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Eric Caumes has a total of 166 co-authors. Here are the top co-authors by number of shared publications:
- Stéphane Jauréguiberry
Université de Paris Saclay, Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital de Bicêtre, Service des Maladies Infectieuses et Tropicales, Le Kremlin Bicêtre, France; Société Française de Médecine des Voyages; Université de Paris Saclay, INSERM, Centre de Recherche en Epidémiologie et Santé des Populations, Villejuif, France
3 shared publications - Valérie Pourcher
Infectious Diseases Department, Pierre-Louis Institute of Epidemiology and Public Health (iPLESP), Inserm U1136, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University, Paris, France
3 shared publications - Alexandre Bleibtreu
Department of Infectious Diseases, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne Université, 75018 Paris, France
2 shared publications - Anastasia Putri
Thai Travel Clinic, Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand
2 shared publications - David Boutolleau
Sorbonne Université, INSERM Sorbonne Public Health Institute Paris France
2 shared publications - Davidson H. Hamer
Department of Global Health, Boston University School of Public Health, Boston, MA, USA
2 shared publications
Latest Publications
- Open Access
Febrile Rash: An Early Diagnostic Clue to Infectious Illness in Travelers Returning from Thailand
The eruption of a rash along with spiking fever in travelers returning from the tropics may be suspicious of arboviral diseases, and isolation prevent further transmission in non-endemic countries. The case presented here was seen at the Fever Clinic at the Hospital for Tropical Diseases in Bangkok, Thailand. The presenting complaints were fever, headache, myalgia, and a distinctive erythematous blanching rash. Despite a negative dengue NS1 test on the initial day, anti-dengue IgM and IgG were detectable on day five of illness. Dengue, a leading cause of traveler’s fever with rash, is of particular concern, especially during outbreaks like the one in Thailand in 2023, when the number of cases exceeded one hundred thousand over a nine-month period. The influx of 28 million travelers in 2023, many with naive immunity to many arboviruses, raises fear of transmission to temperate regions, including to countries like France, where Aedes albopictus establishment can lead to autochthonous dengue cases and clusters. Enhanced surveillance is crucial, urging the consideration of dengue as a potential diagnosis in travelers with febrile rash, even prior to lab confirmation. Immediate isolation of patients is essential to prevent autochthonous transmission, reduce outbreak risks, and avert public health crises.
Open AccessFebrile Rash: An Early Diagnostic Clue to Infectious Illness in Travelers Returning from Thailand
The eruption of a rash along with spiking fever in travelers returning from the tropics may be suspicious of arboviral diseases, and isolation prevent further transmission in non-endemic countries. The case presented here was seen at the Fever Clinic at the Hospital for Tropical Diseases in Bangkok, Thailand. The presenting complaints were fever, headache, myalgia, and a distinctive erythematous blanching rash. Despite a negative dengue NS1 test on the initial day, anti-dengue IgM and IgG were detectable on day five of illness. Dengue, a leading cause of traveler’s fever with rash, is of particular concern, especially during outbreaks like the one in Thailand in 2023, when the number of cases exceeded one hundred thousand over a nine-month period. The influx of 28 million travelers in 2023, many with naive immunity to many arboviruses, raises fear of transmission to temperate regions, including to countries like France, where Aedes albopictus establishment can lead to autochthonous dengue cases and clusters. Enhanced surveillance is crucial, urging the consideration of dengue as a potential diagnosis in travelers with febrile rash, even prior to lab confirmation. Immediate isolation of patients is essential to prevent autochthonous transmission, reduce outbreak risks, and avert public health crises.
- Open Access
- 27 May 2024
- Published by MDPI AG in Preprints.org
Febrile Rash: An Early Diagnostic Clue in Ill-Returning Travelers from the Tropical Region
Eruption of rash along with spiking fever in travelers returning from tropics may be suspicious of arboviral diseases, and isolation can mitigate to prevent further transmission in non-endemic countries. The case presented was seen at the Fever Clinic at Hospital for Tropical Diseases in Bangkok, Thailand. The presenting complaints were fever, headache, myalgia, and a distinctive erythematous blanching rash. Despite a negative dengue NS1 test on the initial day, anti-dengue IgM and IgG were detectable on day five of illness. Dengue, a major cause of traveler’s fever with rash is of particular concern due to outbreak such as Thailand’s, exceeding to over one hundred thousand cases over nine months. The influx of 28 million travelers in 2023, many with naive immunity to many arboviruses, raises fear of transmission to temperature regions. We casually observe this impact in France, where Aedes albopictus presence led to 1099 imported dengue cases from Thailand, resulting in six autochthonous clusters. Heightened vigilance is crucial, urging consideration of dengue as a potential diagnosis in travelers with febrile rash, even prior to lab confirmation. Immediate isolation of patients is essential to prevent autochthonous transmission, reducing outbreak risk and averting public health crises.
- 27 May 2024
- Published by MDPI AG in Preprints.org
Open AccessFebrile Rash: An Early Diagnostic Clue in Ill-Returning Travelers from the Tropical Region
Eruption of rash along with spiking fever in travelers returning from tropics may be suspicious of arboviral diseases, and isolation can mitigate to prevent further transmission in non-endemic countries. The case presented was seen at the Fever Clinic at Hospital for Tropical Diseases in Bangkok, Thailand. The presenting complaints were fever, headache, myalgia, and a distinctive erythematous blanching rash. Despite a negative dengue NS1 test on the initial day, anti-dengue IgM and IgG were detectable on day five of illness. Dengue, a major cause of traveler’s fever with rash is of particular concern due to outbreak such as Thailand’s, exceeding to over one hundred thousand cases over nine months. The influx of 28 million travelers in 2023, many with naive immunity to many arboviruses, raises fear of transmission to temperature regions. We casually observe this impact in France, where Aedes albopictus presence led to 1099 imported dengue cases from Thailand, resulting in six autochthonous clusters. Heightened vigilance is crucial, urging consideration of dengue as a potential diagnosis in travelers with febrile rash, even prior to lab confirmation. Immediate isolation of patients is essential to prevent autochthonous transmission, reducing outbreak risk and averting public health crises.
- 24 May 2024
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 31 (4)
Travel and sex: addressing the spread of sexually transmitted infections
The relationship between travel and STIs is not new. 1 This became obvious after Christopher Columbus discovered the Americas in 1492. According to historical data, some of his troops came back in 1493 with syphilis. The first descriptions of syphilis are attributed to Torrella in 1497 and Villalobos in 1498, in Spain. 2 And two privileged witnesses, Gonzalo Fernández de Oviedo y Valdès (1478–1557) in the ‘Sumario de la natural historia de las Indias’ (1526) and Fray Bartolomé de Las Casas (1484–1566) in the ‘Brevἰsima relación de la destrucción de las Indias’ (1539–1552), supported the New World origin of syphilis. 2 As travel medicine specialists know well, mass gatherings amplify epidemics. 1 And this is exactly what happened with the spread of syphilis after the siege of Naples in Italy (1495). The Spanish confronted the French in the Castel Nuovo, and after the siege, soldiers, mostly mercenaries and sex workers, disseminated syphilis all over Europe. 2 So far, no serious data have challenged this New World hypothesis. Nowadays, hybridization capture and sequencing are developing rapidly in archaeological material. Such studies show that a variety of strains related to both venereal syphilis and yaws-causing Treponema pallidum subspecies were present in Northern Europe in the Early Modern Era. This was not been demonstrated for venereal syphilis before Columbus came back from the Americas. Thus, the current phylogenic approach supports the New World origin of syphilis. 2
- 24 May 2024
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 31 (4)
Travel and sex: addressing the spread of sexually transmitted infections
The relationship between travel and STIs is not new. 1 This became obvious after Christopher Columbus discovered the Americas in 1492. According to historical data, some of his troops came back in 1493 with syphilis. The first descriptions of syphilis are attributed to Torrella in 1497 and Villalobos in 1498, in Spain. 2 And two privileged witnesses, Gonzalo Fernández de Oviedo y Valdès (1478–1557) in the ‘Sumario de la natural historia de las Indias’ (1526) and Fray Bartolomé de Las Casas (1484–1566) in the ‘Brevἰsima relación de la destrucción de las Indias’ (1539–1552), supported the New World origin of syphilis. 2 As travel medicine specialists know well, mass gatherings amplify epidemics. 1 And this is exactly what happened with the spread of syphilis after the siege of Naples in Italy (1495). The Spanish confronted the French in the Castel Nuovo, and after the siege, soldiers, mostly mercenaries and sex workers, disseminated syphilis all over Europe. 2 So far, no serious data have challenged this New World hypothesis. Nowadays, hybridization capture and sequencing are developing rapidly in archaeological material. Such studies show that a variety of strains related to both venereal syphilis and yaws-causing Treponema pallidum subspecies were present in Northern Europe in the Early Modern Era. This was not been demonstrated for venereal syphilis before Columbus came back from the Americas. Thus, the current phylogenic approach supports the New World origin of syphilis. 2
- Top Cited PapersOpen Access
- 16 January 2023
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 30 (2)
Chikungunya: risks for travellers
Chikungunya outbreaks continue to occur, with changing epidemiology. Awareness about chikungunya is low both among the at-risk travellers and healthcare professionals, which can result in underdiagnosis and underreporting. This review aims to improve awareness among healthcare professionals regarding the risks of chikungunya for travellers. Chikungunya virus transmission to humans occurs mainly via daytime-active mosquitoes, Aedes aegypti and Aedes albopictus. The areas where these mosquitoes live is continuously expanding, partly due to climate changes. Chikungunya is characterized by an acute onset of fever with joint pain. These symptoms generally resolve within 1–3 weeks, but at least one-third of the patients suffer from debilitating rheumatologic symptoms for months to years. Large outbreaks in changing regions of the world since the turn of the 21st century (e.g. Caribbean, La Réunion; currently Brazil, India) have resulted in growing numbers of travellers importing chikungunya, mainly to Europe and North America. Viremic travellers with chikungunya infection have seeded chikungunya clusters (France, United States of America) and outbreaks (Italy in 2007 and 2017) in non-endemic countries where Ae. albopictus mosquitoes are present. Community preventive measures are important to prevent disease transmission by mosquitoes. Individual preventive options are limited to personal protection measures against mosquito bites, particularly the daytime-active mosquitos that transmit the chikungunya virus. Candidate vaccines are on the horizon and regulatory authorities will need to assess environmental and host risk factors for persistent sequelae, such as obesity, age (over 40 years) and history of arthritis or inflammatory rheumatologic disease to determine which populations should be targeted for these chikungunya vaccines. Travellers planning to visit destinations with active CHIKV circulation should be advised about the risk for chikungunya, prevention strategies, the disease manifestations, possible chronic rheumatologic sequelae and, if symptomatic, seek medical evaluation and report potential exposures.
- 16 January 2023
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 30 (2)
Top Cited PapersOpen AccessChikungunya: risks for travellers
Chikungunya outbreaks continue to occur, with changing epidemiology. Awareness about chikungunya is low both among the at-risk travellers and healthcare professionals, which can result in underdiagnosis and underreporting. This review aims to improve awareness among healthcare professionals regarding the risks of chikungunya for travellers. Chikungunya virus transmission to humans occurs mainly via daytime-active mosquitoes, Aedes aegypti and Aedes albopictus. The areas where these mosquitoes live is continuously expanding, partly due to climate changes. Chikungunya is characterized by an acute onset of fever with joint pain. These symptoms generally resolve within 1–3 weeks, but at least one-third of the patients suffer from debilitating rheumatologic symptoms for months to years. Large outbreaks in changing regions of the world since the turn of the 21st century (e.g. Caribbean, La Réunion; currently Brazil, India) have resulted in growing numbers of travellers importing chikungunya, mainly to Europe and North America. Viremic travellers with chikungunya infection have seeded chikungunya clusters (France, United States of America) and outbreaks (Italy in 2007 and 2017) in non-endemic countries where Ae. albopictus mosquitoes are present. Community preventive measures are important to prevent disease transmission by mosquitoes. Individual preventive options are limited to personal protection measures against mosquito bites, particularly the daytime-active mosquitos that transmit the chikungunya virus. Candidate vaccines are on the horizon and regulatory authorities will need to assess environmental and host risk factors for persistent sequelae, such as obesity, age (over 40 years) and history of arthritis or inflammatory rheumatologic disease to determine which populations should be targeted for these chikungunya vaccines. Travellers planning to visit destinations with active CHIKV circulation should be advised about the risk for chikungunya, prevention strategies, the disease manifestations, possible chronic rheumatologic sequelae and, if symptomatic, seek medical evaluation and report potential exposures.
- Open Access
- 14 June 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (6) , 1215
Clinical Features and Outcome of Multidrug-Resistant Osteoarticular Tuberculosis: A 12-Year Case Series from France
The optimal treatment for osteoarticular infection due to multidrug-resistant tuberculosis strains (MDR-OATB) remains unclear. This study aims to evaluate the diagnosis, management and outcome of MDR-OATB in France. We present a case series of MDR-OATB patients reviewed at the French National Reference Center for Mycobacteria between 2007 and 2018. Medical history and clinical, microbiological, treatment and outcome data were collected. Twenty-three MDR-OATB cases were reported, representing 3% of all concurrent MDR-TB cases in France. Overall, 17 were male, and the median age was 32 years. Six patients were previously treated for TB, including four with first-line drugs. The most frequently affected site was the spine (n = 16). Bone and joint surgery were required in 12 patients. Twenty-one patients (91%) successfully completed the treatment with a regimen containing a mean of four drugs (range, 2–6) for a mean duration of 20 months (range, 13–27). Overall, high rates of treatment success were achieved following WHO MDR-TB treatment guidelines and individualized patient management recommendations by the French National TB Consilium. However, the optimal combination of drugs, duration of treatment and role of surgery in the management of MDR-OATB remains to be determined.
- 14 June 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (6) , 1215
Open AccessClinical Features and Outcome of Multidrug-Resistant Osteoarticular Tuberculosis: A 12-Year Case Series from France
The optimal treatment for osteoarticular infection due to multidrug-resistant tuberculosis strains (MDR-OATB) remains unclear. This study aims to evaluate the diagnosis, management and outcome of MDR-OATB in France. We present a case series of MDR-OATB patients reviewed at the French National Reference Center for Mycobacteria between 2007 and 2018. Medical history and clinical, microbiological, treatment and outcome data were collected. Twenty-three MDR-OATB cases were reported, representing 3% of all concurrent MDR-TB cases in France. Overall, 17 were male, and the median age was 32 years. Six patients were previously treated for TB, including four with first-line drugs. The most frequently affected site was the spine (n = 16). Bone and joint surgery were required in 12 patients. Twenty-one patients (91%) successfully completed the treatment with a regimen containing a mean of four drugs (range, 2–6) for a mean duration of 20 months (range, 13–27). Overall, high rates of treatment success were achieved following WHO MDR-TB treatment guidelines and individualized patient management recommendations by the French National TB Consilium. However, the optimal combination of drugs, duration of treatment and role of surgery in the management of MDR-OATB remains to be determined.
- 1 March 2021
- Published by Elsevier in Infectious Diseases Now
- Vol. 51 (2) , 140-145
Evaluation of a web-based self-reporting method for monitoring international passengers returning from an area of emerging infection
- 1 March 2021
- Published by Elsevier in Infectious Diseases Now
- Vol. 51 (2) , 140-145
Evaluation of a web-based self-reporting method for monitoring international passengers returning from an area of emerging infection
- 6 January 2021
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 104 (1) , 223-228
Abdominal Tuberculosis: Experience from Two Tertiary-Care Hospitals in the Paris Region
Abdominal tuberculosis (ATB) is uncommon and not very well known by clinicians. We describe the characteristics, evolution, and treatment of patients with ATB in two large hospitals in the Paris region. We reviewed all records of patients treated for ATB, from January 01, 2010 to December 01, 2016, diagnosed by bacteriological and/or histological methods or highly suspected because of clinical/radiological features. We included 80 patients, with a median (IQR) age of 39 (29–50) years, with 56.2% being males. Among them, 63.7% had African origins, 15% Asian, and 11.2% European. Twenty-nine had a cause of immunosuppression (n = 21 HIV infection). The main abdominal localizations were lymph nodes (72.5%), peritoneum (62.5%), and solid organs (25%). Extra-abdominal localizations were recorded in 65 (81.2%) patients. Tuberculosis was proven bacteriologically in 71%, histologically in 50%, and solely clinical/radiological in 10% of cases. Patients received standard therapy for a median duration of 9 months, with a favorable outcome. Corticosteroid therapy was used in 15 cases, either for paradoxical reaction or to prevent complications. Abdominal TB was mainly represented by lymphatic and peritoneal localizations, proven bacteriologically, and associated with extra-abdominal localizations in most cases. The use of steroids remains controversial, but it does not seem systematically needed in case of abdominal involvement.
- 6 January 2021
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 104 (1) , 223-228
Abdominal Tuberculosis: Experience from Two Tertiary-Care Hospitals in the Paris Region
Abdominal tuberculosis (ATB) is uncommon and not very well known by clinicians. We describe the characteristics, evolution, and treatment of patients with ATB in two large hospitals in the Paris region. We reviewed all records of patients treated for ATB, from January 01, 2010 to December 01, 2016, diagnosed by bacteriological and/or histological methods or highly suspected because of clinical/radiological features. We included 80 patients, with a median (IQR) age of 39 (29–50) years, with 56.2% being males. Among them, 63.7% had African origins, 15% Asian, and 11.2% European. Twenty-nine had a cause of immunosuppression (n = 21 HIV infection). The main abdominal localizations were lymph nodes (72.5%), peritoneum (62.5%), and solid organs (25%). Extra-abdominal localizations were recorded in 65 (81.2%) patients. Tuberculosis was proven bacteriologically in 71%, histologically in 50%, and solely clinical/radiological in 10% of cases. Patients received standard therapy for a median duration of 9 months, with a favorable outcome. Corticosteroid therapy was used in 15 cases, either for paradoxical reaction or to prevent complications. Abdominal TB was mainly represented by lymphatic and peritoneal localizations, proven bacteriologically, and associated with extra-abdominal localizations in most cases. The use of steroids remains controversial, but it does not seem systematically needed in case of abdominal involvement.
- 1 January 2021
- Published by Elsevier in Journal of Infection
- Vol. 82 (1) , 159-198
Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19
- 1 January 2021
- Published by Elsevier in Journal of Infection
- Vol. 82 (1) , 159-198
Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19
- Open Access
- 17 November 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (11) , 3691
Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19?
Background: During this pandemic situation, some studies have led to hasty conclusions about Corona Virus Disease-19 (COVID-19) treatment, due to a lack of methodology. This pedagogic study aimed to highlight potential biases in research on COVID-19 treatment. Methods: We evaluate the effect of coffee’s active part, 1,3,7-trimethylxanthine (TMX) on patients with COVID-19. A cohort of 93 patients, with a diagnosis of COVID-19 is analyzed. Results: TMX group and control group included, respectively, 26 and 67 patients. In the TMX group, patients had a median length of stay in hospital of 5.5 days shorter than in the control group (9.5 vs. 15 days, p < 0.05). Patients in the control group were more severe than patients in the TMX group with a significantly higher National Early Warning Score 2 (NEWS-2 score) (8 vs. 6, p = 0.002). Conclusions: Multiple biases prevents us from concluding to an effect of coffee on COVID-19. Despite an important social pressure during this crisis, methodology and conscientiousness are the best way to avoid hasty conclusions that can be deleterious for patients. Identifier: NCT04395742.
- 17 November 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (11) , 3691
Open AccessWhy Methodology Is Important: Coffee as a Candidate Treatment for COVID-19?
Background: During this pandemic situation, some studies have led to hasty conclusions about Corona Virus Disease-19 (COVID-19) treatment, due to a lack of methodology. This pedagogic study aimed to highlight potential biases in research on COVID-19 treatment. Methods: We evaluate the effect of coffee’s active part, 1,3,7-trimethylxanthine (TMX) on patients with COVID-19. A cohort of 93 patients, with a diagnosis of COVID-19 is analyzed. Results: TMX group and control group included, respectively, 26 and 67 patients. In the TMX group, patients had a median length of stay in hospital of 5.5 days shorter than in the control group (9.5 vs. 15 days, p < 0.05). Patients in the control group were more severe than patients in the TMX group with a significantly higher National Early Warning Score 2 (NEWS-2 score) (8 vs. 6, p = 0.002). Conclusions: Multiple biases prevents us from concluding to an effect of coffee on COVID-19. Despite an important social pressure during this crisis, methodology and conscientiousness are the best way to avoid hasty conclusions that can be deleterious for patients. Identifier: NCT04395742.
- 1 July 2020
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 36, 101732
Rasmussen aneurysm in a patient from the Ukraine: A diagnostic challenge
- 1 July 2020
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 36, 101732
Rasmussen aneurysm in a patient from the Ukraine: A diagnostic challenge